Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-2129 for Postoperative Analgesia in Orthopaedics
NCT06780267Phase 2Completed
- Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Start
- Mar 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-2129 in postoperative pain, sponsored by Shandong Suncadia Medicine Co., Ltd.. Started Mar 2025; status: completed.
02
Drugs
HRS-2129
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06780267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06780267.